Elkfork Partners’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $724K | Buy |
16,252
+6,494
| +67% | +$289K | 0.02% | 474 |
|
|
2019
Q2 | $403K | Buy |
9,758
+1,530
| +19% | +$63.2K | 0.01% | 641 |
|
|
2019
Q1 | $333K | Buy |
8,228
+1,734
| +27% | +$70.2K | 0.01% | 671 |
|
|
2018
Q4 | $247K | Sell |
6,494
-12,852
| -66% | -$489K | 0.01% | 714 |
|
|
2018
Q3 | $766K | Hold |
19,346
| – | – | 0.02% | 456 |
|
|
2018
Q2 | $679K | Buy |
19,346
+1,088
| +6% | +$38.2K | 0.02% | 443 |
|
|
2018
Q1 | $638K | Hold |
18,258
| – | – | 0.02% | 462 |
|
|
2017
Q4 | $634K | Hold |
18,258
| – | – | 0.02% | 469 |
|
|
2017
Q3 | $619K | Hold |
18,258
| – | – | 0.02% | 439 |
|
|
2017
Q2 | $622K | Hold |
18,258
| – | – | 0.02% | 437 |
|
|
2017
Q1 | $569K | Hold |
18,258
| – | – | 0.02% | 424 |
|
|
2016
Q4 | $499K | Buy |
+18,258
| New | +$499K | 0.02% | 411 |
|